Epstein File EFTA01034153: Sessions and Session (DS9)

Epstein Index›Documents›EFTA01034153

⚡IMPACT LEVEL 3 — NOTEWORTHY

Epstein File EFTA01034153: Sessions and Session (DS9)

Media / PressDate unavailableEFTA010341531 keyword hits

0

views

0

shares

0

reactions

1

persons

1

keywords

3

excerpts

This document contains a press release and related email correspondence dated September 9, 2019, from Sana Alajmovic regarding Sigrid Therapeutics' presentation of its SiPore product candidate at the American Diabetes Association's 79th Scientific Sessions. The document discusses a late-breaking news presentation of medical research data and does not appear substantively related to the Epstein case.

👤 Named in This Document

Jeff Sessions

🔑 Evidence Keywords

session

📋 Key Excerpts3

PersonKeyword

Excerpt 1

lead product candidate, SiPore TM has been selected for presentation as late breaking news at the American Diabetes Association (ADA) 79th Scientific **Session**

Excerpt 2

From: "Sana Alajmovic" Subject: PRESS RELEASE: Sigrid Therapeutics Presents at the American Diabetes Association 79th Scientific **Sessions** Date: Tue, 09

Excerpt 3

09042019pdf Inline-Images: image001.png Sigrid Therapeutics Announces SiPore1 TM Data Presentation at the American Diabetes Association 79th Scientific **Sessions**